theMednetRegister
  • Community
    • Overview
    • Experts
    • Editors
    • Fellows
    • Code of conduct
    • AI Guidelines for Physicians
  • Company
    • About Us
    • FAQs
    • Privacy Policy
    • Terms of Use
    • Careers
    • Programs
  • News
    • News Releases
    • Press Coverage
    • Publications
    • Blog
  • Contact Us
  • Sign in

Pediatric Hematology/Oncology

Bleeding disorders   

Questions discussed in this category


What is your preferred treatment agent for type 1 von Willebrand patients needing minor procedures if they have a history of severe hyponatremia with DDAVP?
Hyponatremia occurred despite fluid restriction. Do you favor factor replacement? Or do you continue to try DDAVP and add urea +/- salt tablets, in a...
3 Answers available

In which platelet function disorders would you consider use of Novoseven as opposed to platelet transfusion?
Are there particular clinical scenarios that would affect your decision?
1 Answer available
2731110404


Papers discussed in this category


Haemophilia : the official journal of the World Federation of Hemophilia, 2014-03
Desmopressin (DDAVP) in the management of patients with congenital bleeding disorders.

Am J Hematol, 2020 Jul 6
Efficacy and safety of half-dose desmopressin for bleeding prophylaxis in bleeding disorder patients undergoing predominantly low to moderate risk invasive procedures.

Related Topics in Pediatric Hematology/Oncology

  • Lung Cancer
  • Breast Cancer
  • Head and Neck Cancers
  • Hematologic Malignancies
  • Radiation Oncology
  • Gynecologic Oncology
  • Palliation
  • Neuro-Oncology
  • Gastrointestinal Cancers
  • Genitourinary Cancers

Copyright © 2026 theMednet
All Rights Reserved.